Taiwan Advance Bio-Pharmaceutical Inc.

NT$6.72As of Sun 8 Nov 2026, 12:00 UTC
TPEx:4186Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (11.17%)
Div yield —
ROE 6.05%
Biotechnology
Beta (5Y) 0.28
PE TTM 38.74
TSR TTM (48.51%)
Mkt cap NT$604.8M
ROIC 6.61%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$7.32
8.87%
(93.19%)
Hold 10|4|2|6|8
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.07
0.08
0.08
0.08
12.00%
14.02%
13.55%
26.34%
RevenueNT$M
34.66
34.60
35.79
35.87
8.07%
4.89%
7.93%
4.52%
Peers (US$18.21M)
Cap (US$)
PE
18.87M
1,929x
Capital
TTM
5Y
10Y
Leveragex
0.656
0.620
0.446
EBIT/Intx
2.177
0.228
0.192
Own earn%
78.30
(39.16)
(46.96)
Sh yield%
25.81
2.95
2.48
Owners
Insiders/Inst%
5.50
73.91
Short interest%
3.29
SBC / revenue%
2.33
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
0–11
$1 testx
0.0
Incr. ROIC%
3